Status: Recruiting
Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care
This is a prospective, multicentre, randomized clinical trial evaluating the safety, tolerability, and efficacy of up to 12 weeks treatment with SoC + low- or high-dose CYWC628 in treating DFU, compared to SoC only.
Participants needed: 120
Trial details
Phase: Phase 1, Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: FibroBiologicsUpdated: Aug 26, 2026Locations: 9
Eligibility criteria
Males or females aged 18 to 80 years inclusive at time of informed consent. [+14]
The DFU had been previously treated, or is being treated, with growth factors, s... [+15]